Top Banner

of 57

CP Intestinal Obstruction Chap7

Apr 05, 2018

Download

Documents

Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
  • 7/31/2019 CP Intestinal Obstruction Chap7

    1/57

    Chapter VII

    MEDICAL AND NURSING MANAGEMENT

    A. Ideal Diagnostic Tests

    i. Abdominal CT scan - combines special x-ray equipment with

    sophisticated computers to produce multiple images or pictures of

    the inside of the body. These cross-sectional images of the area

    being studied can then be examined on a computer monitor,

    printed or transferred to a CD.

    ii. Abdominal X-Ray - An abdominal X-ray is a picture of structures

    and organs in the belly (abdomen). This includes the stomach,

    liver, spleen, large and small intestines, and the diaphragm, which

    is the muscle that separates the chest and belly areas. Often two X-

    rays will be taken from different positions. An abdominal X-ray may

    be one of the first tests done to find a cause of belly pain, swelling,

    nausea, or vomiting.

    iii. Abdominal Ultrasonography - An ideal clinical tool for determining

    the source of abdominal pain. It can simplify the differential

    diagnosis of abdominal pain, especially when pain and tenderness

    are present over the site of disease.

    http://www.webmd.com/hw-popup/x-rayhttp://www.webmd.com/hw-popup/abdominal-organshttp://www.webmd.com/hw-popup/x-rayhttp://www.webmd.com/hw-popup/abdominal-organs
  • 7/31/2019 CP Intestinal Obstruction Chap7

    2/57

    iv. Barium Enema - X-ray examination of the large intestine (colon

    and rectum). The test is used to help diagnose diseases and other

    problems that affect the large intestine. To make the intestine

    visible on an X-ray picture, the colon is filled with a contrast

    material containing barium. This is done by pouring the contrast

    material through a tube inserted into the anus.

    v. Laboratory studies (e.g., electrolyte studies and a complete blood

    cell count) reveal a picture of dehydration, loss of plasma volume,

    and possible infection.

    B. Ideal Medical Management

    Decompression of the bowel through a nasogastric or small bowel

    tube is successful in most cases. When the bowel is completely

    obstructed, the possibility of strangulation warrants surgical intervention.

    Before surgery, intravenous therapy is necessary to replace the

    depleted water, sodium, chloride, and potassium.

    The surgical treatment of intestinal obstruction depends largely on

    the cause of the obstruction. In the most common causes of obstruction,

    such as hernia and adhesions, the surgical procedure involves repairing

    the hernia or dividing the adhesion to which the intestine is attached. In

    52

    http://www.webmd.com/hw-popup/x-rayhttp://www.webmd.com/hw-popup/large-intestinehttp://www.webmd.com/hw-popup/contrast-materialhttp://www.webmd.com/hw-popup/contrast-materialhttp://www.webmd.com/hw-popup/x-rayhttp://www.webmd.com/hw-popup/large-intestinehttp://www.webmd.com/hw-popup/contrast-materialhttp://www.webmd.com/hw-popup/contrast-material
  • 7/31/2019 CP Intestinal Obstruction Chap7

    3/57

    some instances, the portion of affected bowel may be removed and an

    anastomosis performed. The complexity of the surgical procedure for

    intestinal obstruction depends on the duration of the obstruction and the

    condition of the intestine.

    A colonoscopy may be performed to untwist and decompress the

    bowel. A cecostomy, in which a surgical opening is made into the cecum,

    may be performed for patients who are poor surgical risks and urgently

    need relief from the obstruction. The procedure provides an outlet for

    releasing gas and a small amount of drainage.

    A rectal tube may be used to decompress an area that is lower in

    the bowel. The usual treatment, however, is surgical resection to remove

    the obstructing lesion.

    A temporary or permanent colostomy may be necessary. An

    ileoanal anastomosis may be performed if it is necessary to remove the

    entire large colon.

    C. Ideal Nursing Management

    Nursing management of the nonsurgical patient with a small bowel

    obstruction includes maintaining the function of the nasogastric tube,

    assessing and measuring the nasogastric output, assessing for fluid and

    electrolyte imbalance, monitoring nutritional status, and assessing

    improvement (eg, return of normal bowel sounds, decreased abdominal

    53

  • 7/31/2019 CP Intestinal Obstruction Chap7

    4/57

    distention, subjective improvement in abdominal pain and tenderness,

    passage of flatus or stool). The nurse reports discrepancies in intake and

    output, worsening of pain or abdominal distention, and increased

    nasogastric output. If the patients condition does not improve, the nurse

    prepares him or her for surgery. The exact nature of the surgery depends

    on the cause of the obstruction. Nursing care of the patient after surgical

    repair of a small bowel obstruction is similar to that for other abdominal

    surgeries

    D. Actual Diagnostic Tests

    Fluid Serum

    December 8, 2010

    Electrolytes exist in the blood as acids, bases, and salts (such

    as sodium, calcium,potassium, chloride, magnesium, and bicarbonate).

    They control such things as cardiac function and muscle contraction and

    are routinely measured by laboratory studies of the serum.

    Fluid Serum is the cell-free fluid of the bloodstream. It appears in a

    test tube after the blood clots and is often used in expressions relating to

    the levels of certain compounds in the blood stream.

    54

    http://www.digitalnaturopath.com/treat/T134865.html#G750http://www.digitalnaturopath.com/treat/T134865.html#G539http://www.digitalnaturopath.com/treat/T134865.html#G539http://www.digitalnaturopath.com/treat/T134865.html#G722http://www.digitalnaturopath.com/treat/T134865.html#G650http://www.digitalnaturopath.com/treat/T134865.html#G118http://www.digitalnaturopath.com/treat/T134865.html#G745http://www.digitalnaturopath.com/treat/T134865.html#G750http://www.digitalnaturopath.com/treat/T134865.html#G539http://www.digitalnaturopath.com/treat/T134865.html#G722http://www.digitalnaturopath.com/treat/T134865.html#G650http://www.digitalnaturopath.com/treat/T134865.html#G118http://www.digitalnaturopath.com/treat/T134865.html#G745
  • 7/31/2019 CP Intestinal Obstruction Chap7

    5/57

    A Blood chemistry test is a procedure to examine the general

    health of a patient especially to assess the functioning of certain organs.

    Test Result Reference value Interpretation

    Creatinine 0.8 mg/dl 0.7-1.2 Normal

    Sodium 137 mmol/L 137-145 Normal

    Potassium 3.4 mmol/L 3.5-5.0 Low

    Amylase 37 u/L 30-110 Normal

    Interpretation:

    The table shows that Potassium is slightly decreased. This

    decrease in potassium may be due to patients vomiting, deficient

    potassium intake, or dehydration.

    Nursing Responsibilities:

    define and explain the test

    state the specific purpose of the test

    explain the procedure

    discuss test preparation, procedure, and posttest care

    some blood chemistry tests will have specific requirements such as

    dietary restrictions or medication restrictions.

    55

  • 7/31/2019 CP Intestinal Obstruction Chap7

    6/57

    Complete Blood Count

    December 8, 2010

    The complete blood count (CBC) is one of the most commonly

    ordered blood tests. The complete blood count is the calculation of the

    cellular (formed elements) of blood. These calculations are generally

    determined by special machines that analyze the different components of

    blood in less than a minute.

    This test may be a part of a routine check-up or screening, or as a

    follow-up test to monitor certain treatments. It can also be done as a part

    of an evaluation based on a patient's symptoms.

    Test Results ReferenceValue

    Interpretation

    WBC 12.1 5-10 x 10^9/L High

    Segmenters 0.76 0.55-0.65 High

    Lymphocyte 0.15 0.25-0.35 Low

    Monocyte 0.08 0.03-0.06 High

    Eosinophil 0.01 0.02-0.04 Low

    Hemoglobin 96 140-170 9/L Low

    Hematocrit 0.29 0.40-0.50

    volume

    Low

    Platelet 291 150-350x10^9/L Normal

    56

  • 7/31/2019 CP Intestinal Obstruction Chap7

    7/57

    Interpretation:

    CBC is a combination report of a series of test of the peripheral

    blood. White blood cells (leukocytes) are bodys defense against

    infective organisms and foreign substances. The table shows that there is

    elevated number of WBC which indicates that there is possible infection or

    immunosuppression happening inside.

    Segmenters are above the normal range which indicates infection.

    Low lymphocyte, Eosinophil and Monocyte count indicates that

    the body's resistance to fight infection has been substantially lost and one

    may become more susceptible to certain types of infection, namely cancer

    and tumor. As lymphocyte cells make up fifteen to forty percent of the total

    white blood cells that circulate in the bloodstream, a low count can cause

    damage to organs.

    Hemoglobin is the oxygen carrying protein within the RBCs. The

    table shows that there is decreased hemoglobin concentration in the

    blood, which indicates that there is less oxygen being transported

    throughout the body, because of the less oxygen being transported. With

    this, the patient is likely experiencing difficulty of breathing that leads

    patient to have impaired gas exchange.

    Hematocrit is the percentage of RBC mass to original blood

    volume. The table shows that hematocrit volume is decreased which

    57

    http://www.buzzle.com/articles/cancer/http://www.buzzle.com/articles/cancer/
  • 7/31/2019 CP Intestinal Obstruction Chap7

    8/57

    indicates that there is over expansion of extra cellular fluid volume, since

    the patient has a decreased RBC she also have a decreased hematocrit

    level.

    Nursing Responsibilities:

    Explain that the tests are done to detect any hematologic disorders

    as well as infection and inflammation.

    Tell the patient that a blood sample will be taken and that she may

    feel slight discomfort from the tourniquet and needle puncture.

    Use gloves when collecting and handling all specimens.

    Transport the specimen to the laboratory as soon as possible after

    the collection.

    Do not allow the blood sample to clot, of the results will be invalid.

    Place the specimen in a biohazard bag.

    Abdomen Supine and upright

    December 8, 2010

    Abdominal x-rays may be performed to diagnose causes of

    abdominal pain, such as masses, perforations, or obstruction. Abdominal

    x-rays may be performed prior to other procedures that evaluate the

    58

  • 7/31/2019 CP Intestinal Obstruction Chap7

    9/57

    gastrointestinal (GI) tract or urinary tract, such as an abdominal CT scan

    and renal procedures.

    Result:

    Lung bases are clear. Free subphrenic air is noted. There are gas

    containing loops of small and large bowel in all quadrants with no definite

    pattern. An ovoid soft tissue density is seen in the right lower quadrant

    area overlying pattern of the right superior iliac crest. This is seen in the

    supine view only and may be in the soft tissues. Reacted gas is present.

    There are advance degenerative changes in lumbar spine characterized

    by osteophytes/ spurs formation. Asymmetrical narrowing of L4-L5

    intervertebral joint space, left is seen with linear lucencies within. Mild

    levoseoliosis is noted.

    Impression:

    Essentially (-) study of the abdomen save for degenerative changed

    of the lumbar spine.

    Abdomen Supine and upright

    December 9, 2010

    Re-examination no longer shows the ovoid soft tissue density in the

    right lower quadrant area or seen in the abdominal supine view. Gas

    containing loops of predominantly small bowel segments are still seen in

    59

  • 7/31/2019 CP Intestinal Obstruction Chap7

    10/57

    all quadrants with no definite pattern. Rectal gas is present. Pro-

    peritoneal flank stripes are intact, abdomen are not displaced laterally.

    Nursing Management:

    Remove any clothing, jewelry, or other objects that might interfere

    with the procedure.

    Given a gown to wear.

    Position in a manner that carefully places the part of the abdomen

    that is to be observed. The patient may be asked to stand erect, to

    lie flat on a table, or to lie on the side on a table, depending on the

    x-ray view the physician has requested.

    Body parts not being imaged may be covered with a lead apron

    (shield) to avoid exposure to the x-rays.

    Once positioned, ask the patient to hold still for a few moments

    while the x-ray exposure is made. Also, ask the patient to hold

    his/her breath at various times during the procedure.

    It is extremely important to remain completely still while the

    exposure is made, as any movement may distort the image and

    even require another x-ray to be done to obtain a clear image of the

    body part in question.

    The x-ray beam is then focused on the area to be photographed.

    60

  • 7/31/2019 CP Intestinal Obstruction Chap7

    11/57

    Urinalysis

    December 9, 2010

    Routine urinalysis is performed for general health screening to

    detect renal and metabolic diseases; to diagnose diseases or disorders of

    the kidneys or urinary tract. In addition, it is performed to help diagnose

    specific disorders such as endocrine diseases.

    Physical properties:

    Color Reaction Transparency Specific gravity

    Light yellow 6.0 Clear 1.003

    Chemical reaction:

    Sugar Albumin

    Negative Negative

    Microscopic examination:

    Pus cell RBC

    0.1/ HPF 0.1/ HPF

    Interpretation:

    The physical and chemical properties of the patients urine show

    normal results. Normally, blood must be absent in the urine. Presence of

    blood may indicate acute kidney infections, chronic infections, and stone

    formation in the kidneys.61

  • 7/31/2019 CP Intestinal Obstruction Chap7

    12/57

    Nursing Responsibilities:

    Explain how to collect a clean catch specimen of at least 15 mL.

    Explain that there is no food or fluids restriction.

    Obtain a first voided morning specimen if possible.

    Medications may be restricted for it may affect laboratory results.

    Fecalysis

    December 9, 2010

    It refers to a series of laboratory tests done on fecal samples to

    analyze the condition of a person's digestive tract in general. Among other

    things, a fecalysis is performed to check for the presence of any reducing

    substances such as white blood cells (WBCs), sugars, or bile and signs of

    poor absorption as well as screen for colon cancer.

    Color Chemical and occult

    blood

    Result

    Black Positive No intestinal parasite

    62

  • 7/31/2019 CP Intestinal Obstruction Chap7

    13/57

    seen

    Interpretation:

    Black stool may be a result of possible internal bleeding,

    particularly somewhere in the digestive tract.

    Nursing Responsibilities:

    Discourage patient from taking aspirin, alcohol, vitamin C,

    ibuprofen, and certain types of food if fecal sample will be checked

    for any sign of blood.

    The patient must urinate first to prevent any urine from mixing with

    feces.

    The patient must wear gloves when it's time to handle stool and

    transfer it to a safer container. This will prevent any possibilities of

    being contaminated or infected by bacteria found within the stool.

    Solid and liquid fecal samples are both acceptable as long as they

    do not have urine or other foreign substances like soap, water, and

    toilet paper mixed in them.

    If the patient is suffering from diarrhea, placing a plastic wrap and

    securing it under the toilet seat could facilitate the collection

    process.

    63

  • 7/31/2019 CP Intestinal Obstruction Chap7

    14/57

    Collected samples must be brought to the doctor's office or

    laboratory as soon as possible. Delays could compromise the

    quality of the sample.

    Volume or amount is also important so the patient must be sure he

    has collected an adequate amount of stool.

    Potassium Test

    December 10, 2010

    This test measures the amount of potassium in the blood.

    Potassium (K+) helps nerves and muscles communicate. It also helps

    move nutrients into cells and waste products out of cells.

    Test Result Reference value Interpretation

    Potassium 4.1 3.6-5.0 mmol/L Normal

    Interpretation:

    The potassium level of the patient is normal.

    Ultrasound in the Whole Abdomen

    December 10, 2010

    64

  • 7/31/2019 CP Intestinal Obstruction Chap7

    15/57

    It is an ideal clinical tool for determining the source of abdominal

    pain. It can simplify the differential diagnosis of abdominal pain, especially

    when pain and tenderness are present over the site of disease.

    Result:

    Liver is normal in size and contour. It shows normal homogenous

    echo pattern. No mass lesion is noted. Intrahepatic bile ducts and CBD

    are not dilated. Hepatic vessels are unremarkable. Gallbladder is

    physiologically distended. It shows normal wall thickness. No internal

    echoes are noted. No pevicholecystic fluid collection is seen.

    Pancreas and spleen are normal. Right kidney measures 9.6 x 4.2

    cm with cortical thickness of 1.2 cm. Left kidney measures 9.5 x 4.0 cm

    with cortical thickness of 1.5 cm. Both are normal in size showing

    homogenous corticomedullary parenchymal echogenecity. No echogenic

    focus or mass lesion is noted. There is no separation of the central echo

    complexes. Proximal uterus is not dilated. Uterus is atrophic and is

    compatible with the age of the patient. No abnormal masses are seen in

    both advexac.

    Moderately dilated, fecal-filled segment of large bowel are noted in

    both paracolic gutters, iliac regions and pelvis. No evident mass lesion is

    appreciated.

    65

  • 7/31/2019 CP Intestinal Obstruction Chap7

    16/57

    Impression:

    Considers ileus; Partial obstruction

    Fecal stasis

    Nursing Responsibilities:

    Before procedure, instruct patient to be on NPO 8-12 hrs since air

    or gas can reduce quality of image

    Assess abdominal distention because it may affect quality ofimage

    During procedure, keep the patient in a supine position

    E. Actual Medical Management

    Date Ordered Doctors order Rationale66

  • 7/31/2019 CP Intestinal Obstruction Chap7

    17/57

    December 8,

    2010 (8:39 PM)

    c/c: abdominal

    pain

    T-370C

    PR-92bpm

    RR-24cpm

    BP-

    122/76mmHg

    O2-95

    HG-145

    Please admit room of

    choice under the service

    of Dr. Albano

    NPO

    CBC, serum Amylase

    blood type

    U/A

    Na, K, Creatinine

    Req. X-ray of abdomen

    flat

    For admission and to

    provide quality care.

    In preparation for

    diagnostic tests.

    To diagnose a

    disease and evaluatethe stages of the

    particular disease.

    General health

    screening to detect

    renal and metabolic

    disease.

    To examine the

    general health of a

    patient especially to

    assess the

    functioning of certain

    organs.

    To view the

    obstruction in the

    67

  • 7/31/2019 CP Intestinal Obstruction Chap7

    18/57

    PLR 1 L x 12o

    TPR monitor and record

    Decrease IVF to 60cc/hr

    Fecalysis and stool for

    occult

    Prosec IV now

    intestine.

    To replenish fluid loss

    and electrolyte

    imbalance.

    For baseline data.

    To check for the

    presence of blood.

    For antacids and

    antiulcer function.

    December 8,

    2010 (10:40

    PM)

    Incorporate 30 mEq KCl

    to present IVF

    To provide a direct

    replacement of

    potassium in the

    body.

    December 9,

    2010

    Soft abdomen

    (-) flatus

    Soft diet

    kalium durule TID x 6

    doses

    D5NM x 16o

    To prevent further

    obstruction.

    To provide a direct

    replacement of

    potassium in the

    body.

    To replenish fluid loss

    and electrolyte

    68

  • 7/31/2019 CP Intestinal Obstruction Chap7

    19/57

    Nexium p.o OD

    Motilium tab TID

    imbalance.

    To reduce gastric

    acid secretion.

    To increase the

    movements or

    contractions of the

    stomach and bowel.

    It is also used to treat

    nausea and vomiting.

    December 10,

    2010

    Senokot Forte 2 tabs now

    For Serum test (1:45)

    Ultrasound of whole

    abdomen

    Cleansing enema

    To stimulate

    peristalsis and

    increase intestinal

    motility.

    To examine the

    general health of a

    patient especially to

    assess the

    functioning of certain

    organs.

    For determining the

    source of abdominal

    pain.

    To alleviate

    symptoms of poor

    69

  • 7/31/2019 CP Intestinal Obstruction Chap7

    20/57

    Colonoscopy tomorrow

    12 noon

    Dulcolax 2 tabs tonight

    digestive health.

    To examine colon

    internally.

    It stimulates bowel

    movements.

    December 11,

    2010

    Tympanic

    abdomen

    Senokot Forte 2 tabs BID

    x 3 doses

    Soft diet

    D5LR 1 L x 16o

    D5LR 1 L x 16o (10:35)

    To stimulate

    peristalsis and

    increase intestinal

    motility.

    To prevent further

    obstruction.

    For maintenance of

    nutritional balance.

    December 12,

    2010

    Partial

    obstruction

    Discussed with

    patient/ relative

    (+) BM

    Lactulose 30 cc To increase water

    content in colon and

    enhances peristalsis

    and for the

    breakdown of

    products in colon that

    lead to acidification of

    colonic contents,

    softening of feces,

    and decreased

    ammonia absorption

    from colon to

    70

  • 7/31/2019 CP Intestinal Obstruction Chap7

    21/57

    D5NM 1 L x 16o

    Continue soft diet

    systemic circulation.

    December 13,

    2010

    (-) BM

    11:25 AM

    NPO

    Vomit (3x)

    (-) BM

    (-) flatus x 2

    days

    (+) vomiting

    NPO

    Refer to Dr. Mercado for

    co- management

    D5NM 1 L x 12o

    Give Metoclopramide 1

    amp IVTT now

    Assessment: For surgical

    management - Bowel

    obstruction

    For emergency exlap

    5PM today once cleared

    AP Homez for anesthesia

    For Na+ K+- refer to Dr. A

    Rosete for CP clearance

    No absolute

    contraindication for

    To reduce nausea

    and vomiting.

    To treat large bowel

    obstruction.

    To know the real

    cause of obstruction.

    To assist during

    surgery.

    In preparation for

    surgery.

    71

  • 7/31/2019 CP Intestinal Obstruction Chap7

    22/57

    (-) HPN, (-) DM

    11:20 PM

    surgery (ex-lap)

    Re: acute abdomen-

    intestinal obstruction

    Nebulize with combivent

    1 ampule before transport

    to OR

    Transderm 5mg patch to

    Left Anterior Chest now

    OD

    Secure 2 u of FWB/

    packed RBC for OR use

    Transderm patch- defer if

    BP 90 systolic

    Post-op orders

    To RR x 2o then back to

    room if stable

    O2 at 2-3 LPM

    Flat on bed until fully

    awake

    VS q 15, q 10

    NPO- NGT tip (opened)

    attached to BTB

    IVF right- KVO rate

    BT #1 of packed RBC at

    To assist respiration.

    To replace blood

    loss.

    For respiration.

    To promote

    circulation.

    For monitoring.

    To replace blood

    loss.

    72

  • 7/31/2019 CP Intestinal Obstruction Chap7

    23/57

    11:20 PM

    11:55 PM

    20-25 gtts/min. To follow

    BT as packed RBC BT #2

    IVF left- LR at 30

    gtts/min.

    TF D5LR 1 L x 8o

    Sidedrip- NSS 500 cc +

    voltaren 2 ampules at 20

    cc/hr

    post-op meds

    1. cefuroxime 750 mg q8o

    IVTT

    2. metronidazole left IVF

    500 mg q8o at AM

    3. Omepron 8 AM OD 40

    mg IVTT OD

    4. Voltaren 20 cc/hr

    5. Nebulize with

    Combivent now then q8o

    with volume/ volume

    6. nalbuphine 5 mg q6o x

    12 doses IVTT (6AM-12-

    6-12AM)

    Replace NGT loss q4o

    (volume/ volume

    replacement) To assist the patient

    73

  • 7/31/2019 CP Intestinal Obstruction Chap7

    24/57

    SPO2 95-96%

    11:57 PM

    December 14,

    2010

    10:45 AM

    Patient

    comfortable

    Clear breath

    sounds

    O2 via face mask at 2-3

    LPM RTC

    Attach to pulse oximeter

    at bedside

    Specimen for pathologic

    exam

    Continue nebulization

    every 8o

    D/c O2 supplement

    for enhanced airway.

    For monitoring.

    To assist her

    respiration

    Surgery

    An exploratory laparotomy is done especially when a person

    complains of abdominal pain. The operation allowed the surgeon to

    examine the internal organs. Disease or damage can be uncovered. In

    some cases, the problem can be corrected during the surgery.

    A colostomy is when the colon is cut in half and the end leading to

    the stomach is brought through the wall of the abdomen and attached

    to the skin. The end of the colon that leads to the rectum is closed off

    74

  • 7/31/2019 CP Intestinal Obstruction Chap7

    25/57

    and becomes dormant. Usually a colostomy is performed for infection,

    blockage, or in rare instances, severe trauma of the colon. This is not

    an operation to be taken lightly. It is truly quite serious and demands

    the close attention of both patient and doctor. A colostomy is often

    performed so that an infection can be stopped and/or the affected colon

    tissues can heal.

    F. Actual Nursing Management

    Assess and measure the nasogastric output

    Assess fluid and electrolyte balance and administer IV as

    prescribed

    Monitor nutritional status

    Assess improvement such as return of normal bowel sounds,

    decreased abdominal distention, abdominal pain and

    tenderness, passage of flatus or stool

    Prepare patient for surgery which includes preoperative

    teaching

    After surgery, provide wound care and post-operative nursing

    care

    75

  • 7/31/2019 CP Intestinal Obstruction Chap7

    26/57

    Place ice chips on the same day of surgery to ease the

    patients thirst. By the next day, the patient may be allowed to

    drink clear liquids.

    Slowly add thicker fluids and then soft foods as the bowels

    begin to work again.

    Patient may eat normally within 2 days after the surgery.

    The colostomy drains stool (feces) from the colon into the

    colostomy bag. Most colostomy stool is softer and more liquid

    than stool that is passed normally. The texture of stool

    depends on the location of the segment of intestine used to

    form the colostomy.

    G.Actual Pharmacologic Management (Drug Study)

    Drug # 1

    Date Ordered: Dec. 09, 2010

    Generic Name: esomeprazole magnesium

    Brand Name: Nexium

    Classification:Antiulcer drugs

    Dosage: 40 mg 1 tab OD P.O

    76

  • 7/31/2019 CP Intestinal Obstruction Chap7

    27/57

    Mechanism of Action: Proton pump inhibitor that reduces gastric acid

    secretion and decreases gastric acidity.

    Indications:

    Indicated to Gastroesophageal reflux disease (GERD)

    Healing erosive esophagitis

    Reduce the risk of gastric ulcers in patients receiving continuous

    NSAID therapy.

    Contraindications:

    Contraindicated to patients hypersensitive to drug or components of

    esoprazole or omeprazole.

    Patients receiving continuous NSAID therapy who are at increased

    risk for gastric ulcers include those age 60 and older or those with a

    history of gastric ulcers.

    Adverse Reactions:

    CNS: headache

    GI: dry mouth, diarrhea, abdominal pain, nausea, flatulence,

    vomiting, constipation

    Nursing Responsibilities:

    Give drug at least 1 hour before meals.

    Antacids can be used while taking drug, unless otherwise directed

    by prescriber.

    77

  • 7/31/2019 CP Intestinal Obstruction Chap7

    28/57

    Monitor patient for rash or signs and symptoms of hypersensitivity

    or worsening.

    Monitor GI symptoms for improvement or worsening.

    Instruct patient to take drug exactly as prescribed.

    Health Teachings:

    Tell patient to take drug at least 1 hour before a meal.

    Advise patient that antacids can be used while taking drug unless

    otherwise directed by prescriber.

    Warn patient not to chew or crush drug pellets because this makes

    the drug ineffective.

    Tell patient to inform prescriber of worsening signs and symptoms

    or pain.

    Rationale: To reduce gastric acid secretion.

    Drug # 2

    Date Ordered: Dec. 09, 2010

    Generic Name: potassium chloride

    Brand Name: Kalium Durule

    Classification: Electrolytes and minerals

    Dosage: 1 tab tid x 6 doses

    78

  • 7/31/2019 CP Intestinal Obstruction Chap7

    29/57

    Mechanism of Action: Supplemental potassium in the form of high

    potassium food or potassium chloride may be able to restore normal

    potassium levels.

    Indications:

    For hypokalemia

    As prophylaxis during treatment with diuretics

    Indicated when potassium is depleted by severe vomiting, and

    prolonged diuresis

    Contraindications:

    Severe renal impairment

    Severe hemolytic reactions

    Acute dehydration

    Heat cramps

    Hyperkalemia

    Cautious use in: cardiac or renal disease; systematic acidosis

    Adverse Reactions:

    Renal insufficiency

    Hyperkalemia

    Nausea and Vomiting

    Irritability and Muscle Weakness

    Difficulty in swallowing

    79

  • 7/31/2019 CP Intestinal Obstruction Chap7

    30/57

    Nursing Responsibilities:

    Some patients find it difficult to swallow the large sized KCl tablet.

    Administer while patient is sitting up or standing (never in

    recumbent position) to prevent drug- induced esophagus.

    Dont crush sustained-release potassium products.

    Monitor ECG and electrolyte levels during therapy.

    Monitor for adverse effect that may reflect by perkalemia.

    Health Teachings:

    Tell patient to take with or after meals with full glass of water or fruit

    juice to lessen GI distress.

    Teach patient signs and symptoms of hyperkalemia, and tell patient

    to notify prescriber if they occur.

    Warn patient not to use salt substitutes concurrently, except with

    prescribers permission.

    Rationale: To provide a direct replacement of potassium in the body.

    Drug # 3

    Date Ordered: Dec. 09, 2010

    Generic Name: domperidone

    Brand Name: Motilium

    Classification:Antidiarrheal and Antiemetic

    Dosage: 10 mg 1 tab tid

    80

  • 7/31/2019 CP Intestinal Obstruction Chap7

    31/57

    Mechanism of Action: Gastrointestinal emptying (delayed) adjunct;

    peristaltic stimulant: The gastroprokinetic properties of domperidone are

    related to its peripheral dopamine receptor blocking properties. Motilium

    facilitates gastric emptying and decreases small bowel transit time by

    increasing esophageal and gastric peristalsis and by lowering esophageal

    sphincter pressure. Antiemetic: The antiemetic properties of domperidone

    are related to its dopamine receptor blocking activity at both the

    chemoreceptor trigger zone and at the gastric level.

    Indication: For management of dyspepsia, heartburn, epigastric pain,

    nausea, and vomiting

    Contraindications:

    Known hypersensitivity to domperidone or any of the excipients

    Prolactin-releasing pituitary tumour (prolactinoma).

    Motilium should not be used when stimulation of the gastric motility

    could be harmful:

    Gastro-intestinal haemorrhage, mechanical obstruction or

    perforation.

    Adverse Reactions:

    Immune System Disorder: Very rare; Allergic reaction

    Endocrine disorder: Rare; increased prolactin levels

    81

  • 7/31/2019 CP Intestinal Obstruction Chap7

    32/57

    Nervous system disorders: Very rare; extrapyramidal side effects

    Gastrointestinal disorders: Rare; gastro-intestinal disorders,

    including very rare transient intestinal cramps

    Skin and subcutaneous tissue disorders:Very rare; urticaria

    Reproductive system and breast disorders: Rare; galactorrhoea,

    gynaecomastia, amenorrhoea

    Nursing Responsibilities:

    If clinical symptoms dont improve within 48 hours, stop therapy and

    consider other alternatives.

    Drug produces antidiarrheal action similar to that of diphenoxylate

    but without as many adverse CNS effects.

    Know the patients sensitivity to domperidonebefore giving it.

    Health Teachings:

    Advise patient not to exceed recommended dosage.

    Tell patient with acute diarrhea to stop drug and seek medical

    attention if no improvement occurs within 48 hours. In chronic

    diarrhea, tell patient to notify prescriber and to stop drug if no

    improvement occurs after taking 16 mg daily for at least 10 days.

    Advise patient with acute colitis to stop drug immediately and notify

    prescriber about abdominal distention.

    82

  • 7/31/2019 CP Intestinal Obstruction Chap7

    33/57

    Warn patient to avoid activities that require mental alertness until

    CNS effects of drug are known.

    Rationale: To increase the movements or contractions of the stomach

    and bowel. It is also used to treat nausea and vomiting.

    Drug # 4

    Date Ordered: Dec. 10, 2010

    Generic Name: senna

    83

  • 7/31/2019 CP Intestinal Obstruction Chap7

    34/57

    Brand Name: Senokot Forte

    Classification: Laxatives

    Dosage: 2 tabs bid x3 doses

    Mechanism of action: Unknown. Stimulant laxative that increases

    peristalsis, probably by direct effect on smooth muscle of the intestine. Its

    thought to either irritate the musculature or stimulate the colonic intramural

    plexus. Drug also promotes fluid accumulation in colon and small

    intestine.

    Indication:Acute constipation, preparation for bowel examination.

    Contraindications: Contraindicated in patients with ulcerative bowel

    lesions, fecal impaction, intestinal obstruction, intestinal perforation, or

    signs and symptoms of acute surgical abdomen, such as nausea,

    vomiting, and abdominal pain.

    Adverse reactions:

    GI: nausea, vomiting, diarrhea, loss of normal bowel function with

    excessive use, abdominal cramps, especially in severe

    constipation, malabsorption of nutrients, yellow or yellow-green cast

    to feces, darkened pigmentation of rectal mucosa with long-term

    use, protein losing enteropathy.

    GU: red-pink discoloration in alkaline urine, yellow-brown

    discoloration in acidic urine.

    Metabolic: electrolyte imbalance such as hypokalemia.

    Other: laxative dependence with long-term or excessive use.

    84

  • 7/31/2019 CP Intestinal Obstruction Chap7

    35/57

    Nursing Responsibilities:

    Before giving drug for constipation, determine whether patient has

    adequate fluid intake, exercise and diet.

    Limit diet to clear liquids after X-prep liquid is taken.

    Avoid exposing product to excessive heat or light.

    Drug is for short-term use.

    Health Teachings:

    Teach patient about dietary sources of bulk, including bran and

    other cereals, fresh fruit, and vegetables.

    Tell patient to report persistent or severe reactions.

    Rationale: To stimulate peristalsis and increase intestinal motility.

    Drug # 5

    Date Ordered: Dec. 12, 2010

    Generic Name: lactulose

    85

  • 7/31/2019 CP Intestinal Obstruction Chap7

    36/57

    Brand Name: Duphalac

    Classification: Laxatives

    Dosage: 30 cc now

    Mechanism of Action: Produces an osmotic effect in colon; resulting

    distention promotes peristalsis. Also decreases ammonia, probably as a

    result of bacterial degradation, which lowers the pH of colon contents.

    Indication: Constipation

    Contraindications: Contraindicated in patients on a low galactose diet

    and in those with diabetes mellitus.

    Adverse Reactions:

    GI: abdominal cramps, belching, diarrhea, gaseous distention,

    flatulence, nausea, vomiting.

    Nursing Responsibilities:

    To minimize sweet taste, dilute with water or fruit juice or give with

    food.

    Prepare enema by adding 200 g (300 ml) to 700 ml of water or

    normal saline solution. The diluted solution is given as retention

    enema for 30 to 60 minutes. Use a rectal balloon.

    If enema isnt retained for at least 30 minutes, be prepared to

    repeat dose.

    Monitor sodium level for hypernatremia, especially when giving to

    patients with hepatic encephalopathy.

    86

  • 7/31/2019 CP Intestinal Obstruction Chap7

    37/57

    Monitor mental status and potassium level when giving to patients

    with hepatic encephalopathy.

    Be prepared to replace fluid loss.

    Health Teachings:

    Show home care patient how to mix and use drug.

    Inform patient about adverse reactions and tell him to notify

    prescriber if reactions become bothersome or if diarrhea occurs.

    Instruct patient not to take other laxatives during lactulose therapy.

    Rationale: To increase water content in colon and enhances peristalsis

    and for the breakdown of products in colon that lead to acidification of

    colonic contents, softening of feces, and decreased ammonia absorption

    from colon to systemic circulation.

    Drug # 6

    Date Ordered: Dec. 13, 2010

    Generic Name: cefuroxime

    87

  • 7/31/2019 CP Intestinal Obstruction Chap7

    38/57

    Brand Name: Zegen

    Classification: Antibiotic

    Cephalosporin ( 2nd generation)

    Dosage: 750 mg q8 IVTT

    Mechanism of Action: Cefuroxime is a bactericidal antibiotic, which

    exerts antibacterial activity by inhibition of bacterial cell wall synthesis in

    susceptible species. Cefuroxime has good stability to several bacterial

    beta-lactamase enzymes and, consequently, is active against many

    penicillin-resistant and amoxicillin-resistant strains of susceptible species.

    Indications:

    Lower respiratory tract infections caused by S. pneumoniae, S.

    aureus, E. coli, Klebsiella, H. influenzae, S. pyogenes

    Dermatologic infections caused by S. aureus, S. pyogenes, E. coli,

    Klebsiella, Enterobacter

    UTIs caused by E. coli, Klebsiella

    Uncomplicated and disseminated gonorrhea caused by N.

    gonorrhoea

    Septicemia caused by S. pneumoniae, S. aureus, E. coli, Klebsiella,

    H. influenzae

    Meningitis caused by S. pneumoniae, H. influenzae, S. aureus, N.

    meningitidis

    Bone and joint infections caused by S. aureus

    Perioperative prophylaxis

    88

  • 7/31/2019 CP Intestinal Obstruction Chap7

    39/57

    Contraindications:

    Allergy to cephalosporins or penicillins

    Renal failure

    Adverse Reactions:

    CNS: Headache, dizziness, lethargy, paresthesias

    GI: Nausea, vomiting, diarrhea, anorexia, abdominal pain,

    flatulence, pseudomembranous colitis, liver toxicity

    Hematologic: Bone marrow depression: decreased WBC,

    decreased platelets, decreased Hct

    GU: Nephrotoxicity

    Hypersensitivity: Ranging from rash to fever to anaphylaxis, serum

    sickness reaction

    Local: Pain, abscess at injection site; phlebitis, inflammation at IV

    site

    Other: Superinfections, disulfiram-like reaction with alcohol

    Nursing Responsibilities:

    Assess for history of hepatic and renal impairment

    Observe the 12 rights when administering the drug

    Have vitamin K available in case hypoprothrombinemia occurs

    89

  • 7/31/2019 CP Intestinal Obstruction Chap7

    40/57

    Discontinue if hypersensitivity occurs

    Observe for adverse reactions

    Do not mix with aminoglycosides

    Inject slowly over 3-5min

    Health Teachings:

    Avoid alcohol while taking this drug and 3 days after because

    severe reactions often occurs

    May experience side effects

    Report diarrhea, difficulty in breathing, unusual tiredness or fatigue,

    pain at injection site

    Rationale: To treat the existing acute infection.

    Drug # 7

    Date Ordered: Dec. 13, 2010

    Generic Name: metronidazole

    90

  • 7/31/2019 CP Intestinal Obstruction Chap7

    41/57

    Brand Name: Rosex

    Classification: Amebicide; Antibacterial; Antibiotic; Antiprotozoal

    Dosage: 500mg q8 IVF @ am

    Mechanism of Action: Metronidazole exerts rapid bactericidal effects

    against anaerobic bacteria. It inhibits DNA synthesis, causing cell death.

    Indications:

    Acute infection with susceptible anaerobic bacteria

    Acute intestinal amebiasis

    Amebic liver abscess

    Trichomonias ( acute and partners of patients with acute infection)

    Bacterial vaginosis

    Preoperative, intraoperative, postoperative prophylaxis for patients

    undergoing colorectal surgery

    Prophylaxis for patients undergoing abdominal surgery

    Contraindications:

    Hypersensitivity to metronidazole

    Used cautiously with CNS, hepatic diseases, candidiasis, blood

    dyscrasias

    Adverse Reactions:

    91

  • 7/31/2019 CP Intestinal Obstruction Chap7

    42/57

    CNS: Headache, dizziness, ataxia, vertigo, incoordination,

    insomnia, seizures, peripheral neuropathy, fatigue

    GI : unpleasant metallic taste, anorexia, nausea, vomiting, diarrhea,

    GI upset, cramps

    GU:dysuria, incontinence, darkening of the urine

    Local: thrombophlebitis

    Other: Superinfections , disulfiram-like reaction with alcohol

    Nursing Responsibilities:

    Assess for history of CNS or hepatic disease, candidiasis, blood

    dyscrasias

    Reduce dosage with hepatic disease

    Observe the 12 rights when administering the drug

    Discontinue if hypersensitivity occurs

    Observe for adverse reactions

    Do not refrigerate neutralized solution

    Do not administer solution that has not been neutralized

    Infuse over 1hr

    Discontinue other solutions while running metronidazole

    Protect medication from sunlight

    Health Teachings:

    Take full course of drug therapy

    92

  • 7/31/2019 CP Intestinal Obstruction Chap7

    43/57

    Avoid alcohol while taking this drug and 3 days after because

    severe reactions often occurs

    May experience side effects

    Expect dark colored urine

    Report severe GI upset, dizziness, unusual fatigue or weakness,

    fever, chills

    Rationale: To treat the existing acute infection.

    Drug # 8

    Date Ordered: Dec. 13, 2010

    Generic Name: diclofenac sodium

    Brand Name: Voltaren

    93

  • 7/31/2019 CP Intestinal Obstruction Chap7

    44/57

    Classification: Analgesic (non-opioid); Anti-inflammatory (NSAID);

    Antipyretic

    Dosage: 20cc/hr IV

    Mechanism of Action: Inhibits prostaglandin synthetase to cause

    antipyretic and anti-inflammatory effects; the exact mechanism of action is

    not known.

    Indications:

    Acute or long-term treatment of mild to moderate pain

    Rheumatoid arthritis

    Osteoarthritis

    Ankylating spondylitis

    Contraindications:

    Contraindicated in the presence of significant renal impairment, and

    allergies to NSAIDs

    Use caution in the presence of impaired hearing, allergies, hepatic,

    cardiovascular, and GI conditions and in elderly patients

    Adverse Reactions:

    CNS: Headache, dizziness, somnolence, insomnia, fatigue,

    tiredness, dizziness, tinnitus, ophthamologic effects

    94

  • 7/31/2019 CP Intestinal Obstruction Chap7

    45/57

    GI: Nausea, dyspepsia, GI pain, vomiting, constipation, flatulence,

    diarrhea, GI bleed

    Hematologic: Bleeding, platelet inhibition with higher doses

    GU: Dysuria, renal impairment

    Dermatologic: Rash, pruritus, sweating, dry mucous membranes,

    stomatitis

    Other: Peripheral edema, anaphylactoid reactions to fatal

    anaphylactic shock

    Nursing Responsibilities:

    Assess for history of hepatic and renal impairment, CV and GI

    conditions, impaired hearing

    Observe the 12 rights when administering the drug

    Administer drug with food

    Institute emergency procedures if overdose occurs

    Observe for adverse reactions

    Monitor with use of anticoagulants ( increased risk of bleeding)

    Health Teachings:

    Take drug with food

    95

  • 7/31/2019 CP Intestinal Obstruction Chap7

    46/57

    Take only the prescribed dosage

    May experience side effects

    Report sore throat, fever, rash, itching, weight gain, swelling in

    ankles or fingers, changes in vision, black, tarry stools

    Rationale: This drug is given to alleviate the pain perceived and

    experienced.

    96

  • 7/31/2019 CP Intestinal Obstruction Chap7

    47/57

    Drug # 9

    Date Ordered: Dec. 13, 2010

    Generic Name: omeprazole

    Brand Name: Omepron

    Classification: Antisecretory drug; Proton pump

    inhibitor

    Dosage: 40mg IVTT OD

    Mechanism of Action: Gastric acid pump inhibitor: Suppresses gastric

    acid secretion by specific inhibition of the hydrogen-potassium ATPase

    enzyme system at the secretory surface of the gastric parietal cells; blocks

    the spinal step of acid production

    Indications:

    Short-term treatment of active duodenal ulcer

    Treatment of heartburn or symptoms of GERD

    Short-term treatment of active benign gastric ulcer

    GERD

    Eradication of H. Pylori

    Reduction of risk of upper GI bleeding in critically ill patients

    Contraindications:

    Hypersensitivity to omeprazole or its components

    97

  • 7/31/2019 CP Intestinal Obstruction Chap7

    48/57

    Adverse Reactions:

    CNS: Headache, dizziness, asthenia, vertigo, insomnia, apathy,

    anxiety, paresthesia, dream abnormalities

    GI: Nausea, vomiting, constipation, diarrhea, abdominal pain, dry

    mouth, tongue atrophy

    Dermatologic: Rash, inflammation, urticaria, pruritus, alopecia, dry

    skin

    Respiratory : cough, epistaxis

    Other: back pain, fever

    Nursing Responsibilities:

    Assess for hypersensitivity to omeprazole or its components

    Observe the 12 rights when administering the drug

    Administer with antacids if needed administer before meals

    Observe for adverse reactions

    Health Teachings:

    Take drug before meals and take only the prescribed dosage

    May experience side effects and report severe headache,

    worsening of symptoms, fever, chills

    Rationale: This is given to suppress the gastric secretion and thus,

    reduce the pain perceived.

    98

  • 7/31/2019 CP Intestinal Obstruction Chap7

    49/57

    Drug # 10

    Date Ordered: Dec. 13, 2010

    Generic name: nalbuphine

    Brand name: Nubain

    Classification: Opioid agonist-antagonist

    analgesic

    Dosage: 5mg q6 x 12 doses IVTT

    Mechanism of Action: Nalbuphine acts as an agonist at specific opioid

    receptors in the CNS to produce analgesia and sedation. It inhibits the

    ascending pain pathways, altering the perception of and response to pain

    by binding to opiate receptors in the CNS but also acts to cause

    hallucinations and is an antagonist at mu receptors.

    Indications:

    Relief to moderate to severe pain

    Preoperative analgesia, as a supplement to surgical anesthesia

    Prevention and treatment of intrathecal morphine-induced pruritus after

    CS

    Contraindications:

    Hypersensitivity to nalbuphine, sulfites

    99

  • 7/31/2019 CP Intestinal Obstruction Chap7

    50/57

    Use cautiously with emotionally unstable patients or those with

    history of opioid abuse, bronchial asthma, COPD, respiratory

    depression, anoxia, increased ICP,acute MI

    Adverse Reactions:

    CNS: sedation, clamminess, sweating, headache, nervousness,

    restlessness, depression, crying, confusion, faintness, unusual

    dreams, hallucinations, dizziness, vertigo, floating feeling, feeling of

    heaviness, numbness, tingling, flushing, warmth, blurred vision

    GI: Nausea, vomiting, cramps, dyspepsia, bitter taste dry mouth

    GU: urinary urgency

    Respiratory : respiratory depression, dyspnea, asthma

    Nursing Responsibilities:

    Assess for hypersensitivity to nalbuphine, sulfites, emotional

    instability or history of opioid abuse, bronchial asthma, COPD,

    respiratory depression, anoxia, increased ICP, and MI

    Observe the 12 rights when administering the drug

    Taper dosage when discontinuing after prolonged use to avoid

    withdrawal symptoms

    Reassure patient about addiction liability

    Discontinue if hypersensitivity occurs

    Observe for adverse reactions

    100

  • 7/31/2019 CP Intestinal Obstruction Chap7

    51/57

    Health Teachings:

    May experience side effects

    Avoid performing tasks that require alertness

    For loss of appetite, lying quietly and eating small frequent meals

    may help

    Report severe nausea, vomiting, palpitations, shortness of breath,

    or difficulty in breathing

    Rationale: It is given to alleviate the pain experienced by the patient.

    H. Prognosis

    101

  • 7/31/2019 CP Intestinal Obstruction Chap7

    52/57

    Scoring:

    102

    Poor

    (1)

    Fair

    (2)

    Good

    (3)Justification

    Duration of

    Illness

    She has already a 1 year background of

    intermittent pain on her abdomen and lately,

    she is having difficulty and inability to defecate.The physician believes that symptoms develop

    gradually in time.

    Onset

    She was not diagnosed immediately since she

    doesnt have regular check-ups. It is not clear

    when was obstruction started and how she

    acquired the tumor causing obstruction and

    such manifestations.

    PrecipitatingFactors

    It is fair since she practices healthy lifestyle by

    eating fruits and vegetables. She doesnt have

    any vices like smoking and drinking alcohol.However, the real factors arent clear of what

    aids in developing obstruction caused by the

    tumor.

    Willingness

    to

    Compliance

    of

    Treatment

    When she found out what her condition is, all

    she desires is for her cure and recovery. She

    gives her trust to the health care providers and

    is willing to cooperate with every procedure

    and follows what the physician is saying. She

    is also complying with the medications

    prescribed for her.

    Age

    She is at higher risk because age is a

    predisposing factor that may lead in having

    intestinal obstruction.

    Environment

    She wants a clean environment especially at

    their house. With that, she does household

    chores to maintain neat and organized

    surroundings.

    Family

    Support

    She is well loved and supported by her

    husband, children, and grandchildren. She has

    a close relationship among them.

    Good Fair Poor

    3- 2.7 2.5- 1.6 1- 1.5

  • 7/31/2019 CP Intestinal Obstruction Chap7

    53/57

    The patients score is 2.14 which is a fair prognosis. The patient

    wasnt diagnosed immediately since she already had a one year

    background of abdominal pain. She only then decided to have her check-

    up after having difficulty in defecating. She was admitted and the

    physician advised her o undergo surgery.

    I. Discharge Planning

    When client is to be discharged from the hospital, nursing care is

    still continued. With sufficient support at home, most client recover

    gradually. During home visits, the clients physical status and progress

    103

  • 7/31/2019 CP Intestinal Obstruction Chap7

    54/57

    towards recovery is assessed. The clients understanding of therapeutic

    regimen is also assessed, and previous teaching is reinforced.

    Method

    Instruct the significant others to take the following home medication

    as ordered by the physician.

    Explain to the significant others the drug names as well as the right

    route and dosage.

    Inform the significant others about the side effects that may occur

    brought by the medication.

    Encourage the significant others to comply and follow religiously the

    right timing in taking the medication.

    Confer with the patients family the need take precautions regarding

    medication therapy, activity, and dietary restriction.

    Discuss with the patients family ways to cope with stressful

    situations in positive manner.

    Instruct patients family to report for immediate occurrence of signs

    and symptoms to a health care professional.

    Reinforce and supplement patients family knowledge about

    diagnosis, prognosis, and expected level of function.

    Provide patients family with specific directions about when to call the

    physician and what complications require prompt attention.

    104

  • 7/31/2019 CP Intestinal Obstruction Chap7

    55/57

    Peer support and psychological counseling may be helpful for some

    families.

    Exercise/ Environment

    Once at home, patient may resume much of the normal activity short

    of aggressive physical exercise.

    Walk short distances everyday and gradually increase activity.

    No lifting of a weight greater than 20 lbs (9kg) for 6 weeks. Exercise

    should be started cautiously.

    Encouraged to practice deep breathing exercise and range of motion

    exercises up to the level of capability.

    Explain the need for rest periods both before and after certain

    activities.

    Teach client the importance of stress management through

    relaxation technique, and regular appropriate exercise.

    Help improve patients self-concept by providing positive feedback,

    emphasizing strengths and encouraging social interaction and

    pursuit of interests.

    Treatment

    105

  • 7/31/2019 CP Intestinal Obstruction Chap7

    56/57

    Explain to the significant others the need to continue drug therapy

    Provide patients family with a list of medications, with information on

    action, purpose and possible side effects.

    Advise significant others to always comply with the medications. Call

    the physician if there is a problem taking them.

    If the result of biopsy showed malignancy of the tumor,

    chemotherapy must be followed up.

    Hygiene

    Keep proper hygiene. Teach clients family the importance of hygiene

    like daily oral care, bathing and changing clothes.

    Proper Wound care must be observed.

    Outpatient

    Advise to visit or have her follow up check-up with her attending

    physician.

    Advise to call and notify the attending physician for any unusualities

    that may occur

    106

  • 7/31/2019 CP Intestinal Obstruction Chap7

    57/57

    Routinely, follow up check up with patients within two weeks. If

    there are staples that require removal, postoperative problems, or

    wound issues, a follow-up appointment will be scheduled sooner.

    Diet

    Emphasize to the clients family the importance of proper nutrition, its

    need for early recovery. This can aid in restoring body functioning.

    Provide dietary instructions to help patients family identify and

    eliminate foods that is needed by the patient.

    Soft or low residue diet upon discharge; this should be continued at

    home for approximately 2 weeks (this includes breads, cereals,

    chicken, fish, and soup).

    Avoid large quantities of raw fruits and vegetables.

    After 2 weeks, gradually reintroduce regular diet.

    Encourage to drink plenty of fluids.

    Take nutrition supplements